We are live on ! Find out more
AHCO icon

AdaptHealth

207 hedge funds and large institutions have $1.16B invested in AdaptHealth in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 75 increasing their positions, 62 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $37.2M | Put options by funds: $7.77M

21% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 62

1.74% more ownership

Funds ownership: 85.61%87.35% (+1.7%)

3% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 37

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

1% less funds holding

Funds holding: 210207 (-3)

11% less capital invested

Capital invested by funds: $1.31B → $1.16B (-$146M)

Holders
207
Holders Change
-3
Holders Change %
-1.43%
% of All Funds
2.99%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
38
Increased
75
Reduced
62
Closed
37
Calls
$37.2M
Puts
$7.77M
Net Calls
+$29.4M
Net Calls Change
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
LIP
126
Liontrust Investment Partners
United Kingdom
$236K
CMF
127
Counterpoint Mutual Funds
California
$227K +$111K +10,963 +94%
CA
128
CV Advisors
Florida
$218K
GCP
129
GSA Capital Partners
United Kingdom
$217K +$221K +21,743 New
OAM
130
Oppenheimer Asset Management
New York
$208K +$69.9K +6,879 +49%
ASRS
131
Arizona State Retirement System
Arizona
$205K -$1.53K -151 -0.7%
Neuberger Berman Group
132
Neuberger Berman Group
New York
$200K +$33.8K +3,329 +20%
RJA
133
Raymond James & Associates
Florida
$199K +$40.2K +3,959 +25%
TRCT
134
Tower Research Capital (TRC)
New York
$199K +$191K +18,783 +1,671%
SPA
135
Sherbrooke Park Advisers
New York
$190K -$598K -58,869 -76%
OPERF
136
Oregon Public Employees Retirement Fund
Oregon
$190K -$30.5K -3,000 -14%
IIM
137
INTECH Investment Management
Florida
$185K +$188K +18,454 New
XT
138
XTX Topco
Cayman Islands
$175K -$150K -14,801 -46%
Victory Capital Management
139
Victory Capital Management
Texas
$171K -$144K -14,160 -45%
COPPSERS
140
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$168K -$8.53K -839 -5%
Creative Planning
141
Creative Planning
Kansas
$166K +$169K +16,609 New
SOW
142
State of Wyoming
Wyoming
$165K -$140K -13,791 -46%
AIM
143
Aigen Investment Management
New York
$158K +$161K +15,839 New
HI
144
Humankind Investments
New York
$157K +$160K +15,747 New
Handelsbanken Fonder
145
Handelsbanken Fonder
Sweden
$155K -$12.2K -1,200 -7%
FA
146
Fiduciary Alliance
South Carolina
$154K -$264K -26,000 -62%
Los Angeles Capital Management
147
Los Angeles Capital Management
California
$151K +$154K +15,115 New
SC
148
Savant Capital
Illinois
$147K +$150K +14,727 New
EGM
149
Engineers Gate Manager
New York
$145K -$150K -14,760 -50%
Zurich Cantonal Bank
150
Zurich Cantonal Bank
Switzerland
$145K

AHCO Hedge Fund Activity: Q2 2024 in Review

207 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2024, worth a combined $1.16B — down 11% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new AHCO positions and 37 closed out — a net gain of 1 holder — while 75 added to existing stakes and 62 trimmed.

The largest buyer was Segall Bryant & Hamill, adding an estimated $8.02M. The largest seller was Silvercrest Asset Management, exiting entirely with an estimated $12.6M sold.

  • 207 institutional investors held AdaptHealth (AHCO) as of Q2 2024, down from 210 in Q1 2024.
  • Funds reported $1.16B of AdaptHealth stock for Q2 2024, down 11% quarter-over-quarter.
  • 38 funds opened new AdaptHealth positions in Q2 2024 and 37 closed out, a net change of +1 holder.
  • The largest AdaptHealth buyer in Q2 2024 was Segall Bryant & Hamill, an estimated $8.02M added.
  • The largest AdaptHealth seller in Q2 2024 was Silvercrest Asset Management, an estimated $12.6M sold.

Based on aggregated 13F filings for Q2 2024.